New registry tracks cannabis use in cancer patients to guide symptom relief

NCT ID NCT07227324

Recruiting now Knowledge-focused Sponsor: HealthPartners Institute Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This registry study is collecting real-world data from 1,000 adults with cancer who use cannabis. Participants use an app to track symptoms, cannabis use, and changes in other medications. The goal is to help patients and doctors make informed decisions about using cannabis for symptom management.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: cannabis
What this could lead to: If successful, this registry could provide reliable data to help cancer patients and their doctors decide whether cannabis might help manage symptoms like pain or nausea.
What could go wrong: This is an observational registry, not a controlled trial, so it cannot prove cause and effect. Results may be influenced by patient self-reporting and other factors.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cancer cannabis dependence neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CANCER CANNABIS USE

Contacts and locations

Locations

HealthPartners Institute Cancer Research Center
RECRUITING

Saint Louis Park, Minnesota, 55426, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.